A novel variant with a severe phenotype in a patient with CARD14-associated papulosquamous eruption successfully treated with ixekizumab.

Ouyang, Xiaoliang; Zhang, Deng; Wang, Xiuping; Wu, Liang; Xiao, Zhen; Zhu, Yunxia; Yu, Simin; Li, Chunming

Ouyang, Xiaoliang; Zhang, Deng; Wang, Xiuping; Wu, Liang; Xiao, Zhen; Zhu, Yunxia; Yu, Simin; Li, Chunming.

Affiliation

Ouyang X; Departments of Plastic Surgery.
Zhang D; Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.
Wang X; Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.
Wu L; Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.
Xiao Z; Department of Dermatology, Taiyuan Central Hospital, Taiyuan, Shanxi, People's Republic of China.
Zhu Y; Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.
Yu S; Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.
Li C; Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.

Clin Exp Dermatol ; 49(6): 661-664, 2024 May 21.

Article in En | MEDLINE | ID: mdl-38197442

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CARD Signaling Adaptor Proteins / Antibodies, Monoclonal, Humanized / Guanylate Cyclase Type of study: Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Clin Exp Dermatol Year: 2024 Document type: Article Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google